NxStage Announces Third Quarter 2013 Investor Conference Schedule

LAWRENCE, Mass., July 31, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer and Matthew Towse, Chief Financial Officer will participate in the following schedule of investor conferences.  A webcast of the event will be made available at http://ir.nxstage.com/ at the time of each conference.  

(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO)

Canaccord Genuity 33^rd Annual Growth Conference
Intercontinental Hotel
Boston, MA
Thursday, August 15, 2013
2:00 pm ET

CL King's 11th Annual Best Ideas Conference 2013
Omni Berkshire Place Hotel
New York, NY
Thursday, September 12, 2013

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at http://www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Messrs. Burbank and Towse's plans to present at these conferences.  NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage's expectations or beliefs as of any date subsequent to the date of this press release.

Contact:

Kristen K. Sheppard, Esq.
Investor Relations
ksheppard@nxstage.com

SOURCE NxStage Medical, Inc.